Genetic variants in acylphosphatase 2 (ACYP2) and Wolframin ER transmembrane glycoprotein (WFS1) were identified as predictive markers for hearing loss [13,14,15,16,17]. This evidence concerns the gene WFS1 and hearing loss disorder.